Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Zug
SEC filing record 1 source field available
Fiscal year end
31 December
CRISPR Therapeutics AG has filed 858 SEC EDGAR filings since 13 May 2016

SEC filing history

Showing 676-700 of 858 matching filings.

Per page
25
Current page
28
4

FORM 4 SUBMISSION

Filing date
27 Dec 2017
Reporting date
22 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Dec 2017
Reporting date
22 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Dec 2017
Reporting date
21 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-89674

SC 13D/A

Filing date
26 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-37923

CT ORDER filing

Filing date
21 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
21 Dec 2017
Reporting date
20 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Dec 2017
Reporting date
15 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

FORM 8-K

Filing date
18 Dec 2017
Reporting date
12 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Dec 2017
Reporting date
03 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
07 Dec 2017
Reporting date
07 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-89674

SC 13D/A

Filing date
06 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Dec 2017
Reporting date
01 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-221491

EFFECT filing

Filing date
04 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-221491

S-3/A

Filing date
01 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
01 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Nov 2017
Reporting date
24 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Nov 2017
Reporting date
24 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Nov 2017
Reporting date
13 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Nov 2017
Reporting date
13 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
13 Nov 2017
Reporting date
10 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-221491

S-3

Filing date
09 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-221427

S-8

Filing date
08 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
08 Nov 2017
Reporting date
08 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .